InvestorsHub Logo
Followers 5
Posts 770
Boards Moderated 0
Alias Born 08/31/2016

Re: techxen post# 23498

Saturday, 06/27/2020 7:57:26 AM

Saturday, June 27, 2020 7:57:26 AM

Post# of 27429
Techxen, the only number that hasn't made sense to me thus far is the number of CV patients treated by Cytosorb. It's extremely low in my opinion. The last number that we heard was 750 patients. Hospitals may be ordering at a rapid rate, but are they using the filters? I was hoping to see the number of patients treated by Cytosorb in the thousands. That would get me more excited. Maybe we will see a larger increase during the Q2 earnings call.

I will continue to be disappointed with the lack of information coming from the company. In late March/early April, there were updates almost weekly. This week's PR was the first that we heard from the company in 3 weeks. I see no advertising for Cytosorb...why?

Too many questions still that need to be answered. Let's hope for a big revenue number from not only CV but from the company's normal business.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News